Ayabudge LLC - 13 Dec 2022 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
10%+ Owner
Signature
/s/ Ayabudge LLC by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
13 Dec 2022
Net transactions value
-$1,945,509
Form type
4
Filing time
15 Dec 2022, 18:46:49 UTC
Previous filing
19 Sep 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale $937,200 -330,000 -1.7% $2.84 18,600,004 13 Dec 2022 Direct F1, F2
transaction HUMA Common Stock Sale $762,599 -276,304 -1.5% $2.76 18,323,700 14 Dec 2022 Direct F1, F3
transaction HUMA Common Stock Sale $245,710 -93,426 -0.51% $2.63 18,230,274 15 Dec 2022 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 13, 14 and 15, 2022, the Reporting Person sold 330,000, 276,304 and 93,426 shares of Common Stock, respectively. The transactions enabled Mr. Brady W. Dougan, a person controlling the Reporting Person, to pay down leverage while providing a mechanism for the purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase. Mr. Dougan, directly and indirectly, remains the largest shareholder of the Issuer.
F2 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.77 to $3.06. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.75 to $2.87. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.60 to $2.80. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.